CoChat

Osteoblast-Derived Lipocalin-2 Regulated by miRNA-96-5p/Foxo1 Advances the Progression of Alzheimer’s Disease

Wu, Bo-Wen, Guo, Jin-Dong, Wu, Mi-Shan, Liu, Yu, Lu, Meng, Zhou, Yu-Hui, Han, Hong-Wei · 2020 · Epigenomics

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Aim: Alzheimer’s disease (AD) is the most frequent cause of dementia and characterized by the accumulation of β-amyloid peptides in plaques and vessel walls. This study proposed a hypothesis of an inhibitory role of miR-96-5p in AD via regulating Foxo1. Methods & methods: AD mouse models were established by injecting with 1% pentobarbital. Results: Knockdown of miR-96-5p in the presence of naringin was shown to reduce the expression of Foxo1 and contents of superoxide dismutase, catalase and glutathione peroxidase, yet increase lipocalin-2 expression as well as hydroxyproline and malondialdehyde contents. Also, Foxo1-mediated lipocalin-2 inhibition attenuated AD. Conclusion: Our study shows downregulating miR-96-5p limited AD progression, highlighting miR-96-5p a potential therapeutic target in treating AD.

Overview

Integrity signals

Registry

Crossref · 10.2217/epi-2019-0215

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 31 · Cited by 20

Metadata

Authors
Wu, B.-W., Guo, J.-D., Wu, M.-S., Liu, Y., Lu, M., Zhou, Y.-H., & Han, H.-W.
Affiliations
  • Department of Biochemistry, Basic Medicine College, Hebei University of Chinese Medicine, Shijiazhuang050200, Hebei Province, PR China
  • Hebei University of Chinese Medicine (CN)
  • Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Shijiazhuang050091, Hebei Province, PR China
Venue
Epigenomics
Published
2020-09
Volume
12
Issue
17
Pages
1501-1513
ISSN
  • 1750-1911 (ISSN-L)
  • 1750-192X
OpenAlex
W3083904160
Cited by
20
References
31
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2022: 6 · 2021: 4 · 2020: 1
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Locations
  • Epigenomics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Key Scientific and Technological Research Projects of Colleges and Universities in Hebei Province (ZD2019129)
  • Research and Research Ability Construction of Traditional Chinese Medicine Resources and Research on Classical Chinese Medicine Documents and Inheritance Schools (21810027)
  • Hebei University of Traditional Chinese Medicine
  • Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Master’s Degree Innovation Funding Project of Hebei Province (CXZZSS2020075)
  • , Key R&D Plan of Provincial Science and Technology Plan of Science and Technology Department of Hebei Province in 2019 (19277720D)
  • Scientific and Technological Ability of Hebei University of Traditional Chinese Medicine in 2019 (KTZ2019017)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, miR-96-5p, FOXO1, neutrophil gelatinase-associated lipocalin, osteoblasts, oxidative stress, antioxidant enzymes, naringin, therapeutic target
MeSH terms
Lipocalin-2, Forkhead Box Protein O1, Alzheimer Disease, Animals, Disease Models, Animal, Disease Susceptibility, Gene Expression Regulation, Osteoblasts, Biomarkers, Disease Progression, RNA Interference, MicroRNAs, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Osteoblast-Derived Lipocalin-2 Regulated by miRNA-96-5p/Foxo1 Advances the Progression of Alzheimer’s Disease. https://app.cochat.ai/papers/10.2217/epi-2019-0215
The paper
Wu, B.-W., Guo, J.-D., Wu, M.-S., Liu, Y., Lu, M., Zhou, Y.-H., & Han, H.-W. (2020). Osteoblast-Derived Lipocalin-2 Regulated by miRNA-96-5p/Foxo1 Advances the Progression of Alzheimer’s Disease. Epigenomics. https://doi.org/10.2217/epi-2019-0215

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.